A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase

A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase

Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) protects against cardiovascular disease by metabolising the risk factor asymmetric dimethylarginine (ADMA). However, the question whether the second DDAH isoform, DDAH2, directly metabolises ADMA has remained unanswered. Consequently, it is...

Full description

Bibliographic Details
Main Authors:	Vinitha N. Ragavan, Pramod C. Nair, Natalia Jarzebska, Ramcharan Singh Angom, Luana Ruta, Elisa Bianconi, Silvia Grottelli, Natalia D. Tararova, Daniel Ryazanskiy, Steven R. Lentz, Sara Tommasi, Jens Martens-Lobenhoffer, Toshiko Suzuki-Yamamoto, Masumi Kimoto, Elena Rubets, Sarah Chau, Yingjie Chen, Xinli Hu, Nadine Bernhardt, Peter M. Spieth, Norbert Weiss, Stefan R. Bornstein, Debabrata Mukhopadhyay, Stefanie M. Bode-Böger, Renke Maas, Ying Wang, Antonio Macchiarulo, Arduino A. Mangoni, Barbara Cellini, Roman N. Rodionov
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-06-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-38467-9

Similar Items

Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
by: Julie-Ann Hulin, et al.
Published: (2020-01-01)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01)

Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1
by: Ying Wang, et al.
Published: (2021-10-01)

Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
by: Frank Leypoldt, et al.
Published: (2009-10-01)

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.
by: Francesco Andreozzi, et al.
Published: (2012-01-01)

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
by: Ziang Xie, et al.
Published: (2022-01-01)

Gene therapy for dysfunctional endothelium: is dimethylarginine dimethylaminohydrolase-2 a therapeutic target?
by: Tousoulis, D, et al.
Published: (2010)

MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
by: Julie-Ann Hulin, et al.
Published: (2017-10-01)

Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma.
by: Kayla G Kinker, et al.
Published: (2014-01-01)

Overexpression of Dimethylarginine Dimethylaminohydrolase Enhances Tumor Hypoxia: An Insight into the Relationship of Hypoxia and Angiogenesis In Vivo
by: Vassiliki Kostourou, et al.
Published: (2004-07-01)

Exploring the role of dimethylarginine dimethylaminohydrolase-mediated reduction in tissue asymmetrical dimethylarginine levels in cardio-protective mechanism of ischaemic postconditioning in rats
by: Kamaldeep Kaur, et al.
Published: (2019-12-01)

Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension.
by: Karsten Sydow, et al.
Published: (2012-01-01)

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
by: Lin Shing-Jong, et al.
Published: (2011-02-01)

Cerebral changes occurring in arginase and dimethylarginine dimethylaminohydrolase (DDAH) in a rat model of sleeping sickness.
by: Donia Amrouni, et al.
Published: (2011-03-01)

Dimethylarginine dimethylaminohydrolase 1 protects PM2.5 exposure-induced lung injury in mice by repressing inflammation and oxidative stress
by: Junling Gao, et al.
Published: (2022-10-01)

Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice
by: Tommaso Ceruti, et al.
Published: (2023-12-01)

Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity
by: Simon Lambden, et al.
Published: (2018-12-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Dimethylarginine Dimethylaminohydrolase/Nitric Oxide Synthase Pathway in Liver and Kidney: Protective Effect of Cyanidin 3-<em>O</em>-β-D-Glucoside on Ochratoxin-A Toxicity
by: Rosaria Acquaviva, et al.
Published: (2012-05-01)

Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling
by: Roman N. Rodionov, et al.
Published: (2022-06-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema
by: Hans Worthmann, et al.
Published: (2017-12-01)

Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.
by: Ibrahim Musa Yola, et al.
Published: (2021-01-01)

Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
by: Juliane Hannemann, et al.
Published: (2020-09-01)

Correction: Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Shufen Chen, et al.
Published: (2023-05-01)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
by: Tzong-Shyuan Lee, et al.
Published: (2021-10-01)

Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
by: Kathrin Cordts, et al.
Published: (2019-07-01)

Association of angiopoietin-2 and dimethylarginines with complicated course in patients with leptospirosis.
by: Alexander Lukasz, et al.
Published: (2014-01-01)

Comparison of two methods for dimethylarginines quantification
by: Vendula Sudová, et al.
Published: (2024-03-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Renal asymmetric dimethylarginine inhibits fibrosis
by: Ming Wu, et al.
Published: (2020-10-01)

Dimethylarginine: Biomarkers in progression of kidney disease
by: Cvetković Tatjana, et al.
Published: (2012-01-01)

Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020-08-01)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
by: Dimitrios Tsikas, et al.
Published: (2018-01-01)

Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.
by: Oktay Tutarel, et al.
Published: (2012-01-01)

Response to Asymmetrical Dimethylarginine, Oxidative Stress, and Atherosclerosis
by: Antoniades, C, et al.
Published: (2011)

Levels of dimethylarginines and cytokines in mild and severe preeclampsia.
by: Ellis, J, et al.
Published: (2001)

Dimethylarginines in Children after Anti-Neoplastic Treatment
by: Michalina Jezierska, et al.
Published: (2022-01-01)

Asymmetric dimethylarginine levels in patients with diabetic nephropathy
by: Sarvari G, et al.
Published: (2016-10-01)

Study of endothelial dysfunction and asymmetric dimethylarginine levels
by: Ya. V. Sirman, et al.
Published: (2019-10-01)